Actually, it was reported that GM treatment exhibited lower incidence of infections with a risk ratio (RR, 95% CI) of 0.99 (0.79–1.24) as compared to infliximab, another TNFα blockers with a RR of 1.23 (0.94–1.61) (37). Here, TNF is linked to infection.